AbbVie Inc. (NYSE:ABBV)

tprooney3 (64.45) Submitted: 5/20/2013 12:17:47 PM : Start Price: $46.68 ABBV Score: -0.16

Institutional investors have yet to buy

jimfranko (64.80) Submitted: 5/17/2013 7:54:37 PM : Start Price: $44.31 ABBV Score: +1.29

http://www.abbvie.com

j8h9 (< 20) Submitted: 5/8/2013 6:01:37 PM : Start Price: $43.34 ABBV Score: +4.99

Fantastic dividend and growth here. This is Abbotts business

kainvest (47.66) Submitted: 4/16/2013 11:43:02 AM : Start Price: $41.63 ABBV Score: +5.18

Could be in sweet spot for market performance

IfHeDiesHeDies (43.83) Submitted: 4/8/2013 7:21:52 PM : Start Price: $41.58 ABBV Score: +5.12

A+

DirkaDirka (71.44) Submitted: 3/15/2013 6:18:57 PM : Start Price: $36.64 ABBV Score: +14.31

Some P/E ratios for comparison:
BMY 33.79
MRK 21.99
PFE 22.24
JNJ 20.50

And...
ABBV 12.44

P/E isn't everything, but ROE and ROA are pretty outstanding as well in comparison. Yes there are worries about being reliant on one drug, but there's plenty of time to bail if nothing promising comes down the pipeline. In the meantime, revenues from Humira are increasing, which means good things for about 2 more years at least. This is a classic undervalued spinoff, despite the large size.

DCUDFlyer (25.95) Submitted: 3/12/2013 9:56:49 AM : Start Price: $37.64 ABBV Score: +16.45

Happy owner in real life...value, yield and low beta.

ausgmblr (< 20) Submitted: 2/5/2013 7:17:24 PM : Start Price: $36.84 ABBV Score: +15.37

MEDICAL SEC. result of 2/1 split from ABT last month should be good appreciation.

TheBoodist (62.20) Submitted: 1/18/2013 11:10:59 AM : Start Price: $36.17 ABBV Score: +15.47

Since it is new, it will be sold hard, and it's a split from ABT which I have in my Roth IRA. Beyond a few months though, I'm ot sure.

twocoins (79.47) Submitted: 1/17/2013 11:21:41 AM : Start Price: $36.01 ABBV Score: +16.11

This is Abbott Labs all over again. I think it is going to fly. Simply my own opinion knowing we have most of the very same people running this new company.

2trpop (84.25) Submitted: 1/13/2013 10:57:08 AM : Start Price: $34.02 ABBV Score: +22.43

Dividend Payout
POSTED AT 1/11/2013 7:09:37 PM
The stock ABBV has paid out a dividend of $0.4. The starting price for your pick has been adjusted to reflect the value of this dividend payout.

usubanas (99.51) Submitted: 1/10/2013 2:29:39 AM : Start Price: $34.27 ABBV Score: +20.57

My favorite dividend-paying stock: 4.7% yield and very promising early stage pipeline. I particularly like ABT-199:

http://biotechstrategyblog.com/2013/01/ash-2012-abt-199-shows-promise-in-cll-and-mcl.html/

cabostacos (24.70) Submitted: 1/8/2013 12:22:24 AM : Start Price: $33.58 ABBV Score: +23.88

They are the hands down frontrunner in regards to treating the genotype 1 hep c patients.
gilead is painting a picture of big success but if you look deeper they are using geno 2 when in reality, the hard to treat prevelent geno 1 null responders are being sent home without SVR 1 in 10 clears

chk999 (99.98) Submitted: 1/2/2013 8:02:20 PM : Start Price: $34.27 ABBV Score: +21.29

Spinoffs usually do better than the parent company.